Table 2 Clinical parameters of patients with and without HT
From: Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke
HT (%) | OR (5% CI) | p | |
|---|---|---|---|
SBP, mmHga | |||
< 140 | 3/67 (4.5) | ||
≥ 140 | 4/48 (8.3) | 1.9 (0.4–9) | 0.4 |
DBP, mmHga | |||
< 80 | 5/74 (6.8) | ||
≥ 80 | 2/41 (4.9) | 0.7 (0.1–3.8) | 0.7 |
Platelets, 103/µla | |||
< 214 | 3/57 (5.3) | ||
≥ 214 | 4/57 (7.0) | 0.7 (0.15–3.4) | 0.6 |
INR* | |||
< 1 | 2/36 (5.6) | ||
≥ 1 | 5/74 (6.8) | 1.2 (0.2–6.7) | 0.6 |
Total cholesterol, mg/dla | |||
< 193 | 3/51 (5.9) | ||
≥ 193 | 4/53 (7.5) | 1.3 (0.3–6.1) | 0.7 |
HDL, mg/dla | |||
< 45.5 | 4/63 (6.3) | ||
≥ 45.5 | 3/37 (8.1) | 0.8 (0.1–3.6) | 0.7 |
LDL, mg/dla | |||
< 109.4 | 4/40 (10.0) | ||
≥ 109.4 | 2/49 (4.0) | 0.4 (0.06–2.2) | 0.3 |
Triglycerides, mg/dla | |||
< 113.5 | 3/38 (7.9) | ||
≥ 113.5 | 4/66 (6.0) | 0.7 (0.1–3.5) | 0.7 |
Blood glucose, mg/dla | |||
< 125.5 | 3/74 (4.0) | ||
≥ 125.5 | 4/38 (10.5) | 2.8 (0.6–13.1) | 0.2 |